Market Overview

I think you’ll love what you hear,
what you’ll see and the opportunities
that will be set before you.
- Jon Najarian
GET TICKETS

Abercrombie Soared On Q4 Earnings, But The Chart Still Shows A Buying Opportunity Ahead

Share:

Summary:

  • Abercrombie & Fitch Co. (NYSE: ANF) soared over 20 percent higher on Wednesday after posting earnings that beat Wall Street expectations.
  • While the stock is likely heading even higher, we believe it is likely to pullback first.

Abercrombie & Fitch Stock Weekly Chart

The company reported earnings per share of $1.35 and total revenue of $1.15 billion, compared to analyst estimates of $1.2 and $1.13 billion. Management forecast annual sales to rise 2-4 percent, which also exceeded expectations. Further, the company is considering closing up to 40 stores, having already closed nearly 500 over the last eight years.

Our approach to projecting the price action combines analyzing the stock’s market cycles with traditional technical analysis. After reviewing the cycles for Abercrombie, it is likely still in the rising phase of its current cycle, approaching a brief corrective period in coming weeks.

The stock has now repaired itself, after making a double top and losing over 50 percent of its value. This rise suggests improved longer-term prospects. The intermediate cycles imply a brief pullback is likely over the next few weeks, which would likely be a buying opportunity, with a projection near $26.50 in coming months.

Related Links:

Mid-Afternoon Market Update: Dow Down Over 100 Points; Bio-Path Shares Spike Higher

Mid-Day Market Update: Abercrombie & Fitch Gains Following Upbeat Q4 Results; Valeritas Shares Slide

The preceding article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.

 

Related Articles (ANF)

View Comments and Join the Discussion!

General Electric's Power Business Is Flickering, Company 'Long Way' From Seeing Turnaround

Mid-Afternoon Market Update: Dow Down Over 100 Points; Bio-Path Shares Spike Higher